Category: Covid-19

Page 330«..1020..329330331332..340350..»

Ventilation helps make public transit safer from spread of Covid-19, experts say, but masks are better – CNN

April 20, 2022

CNN

Although a federal judge struck down the Biden administrations mask mandate for public transportation Monday, some experts say you dont want to throw out your mask just yet. No matter the form of public transportation planes, trains, trams, subways, buses or even rideshares good ventilation can help reduce the spread of Covid-19, but masks work best.

You cant engineer your way out of a problem like this, said Krystal Pollitt, an assistant professor of epidemiology and assistant professor in chemical and environmental engineering at the Yale Institute for Global Health.

Someone infected with Covid-19 releases aerosols that contain the coronavirus when they talk, laugh or simply exhale. If the person isnt wearing a mask to block those aerosols, they can hang in the air and be inhaled by other people nearby.

Outdoors, viral particles may disperse with even a light wind. But indoors, where there is no wind, particles tend to concentrate and hang around. Good ventilation can help break up the concentration of viral particles, but it cant do everything.

Ventilation is great, but we know if we are outside, the risks are lower. Being able to re-create the same amount of airflow that you would have with just your natural wind patterns in a confined indoor space thats heavily occupied is incredibly hard to do, Pollitt said. Outside of putting yourself into, say, a wind tunnel, which obviously wouldnt be comfortable for many reasons or energy-wise, we have to think about whats realistic.

On public transportation of any kind, a heating, ventilation and air-conditioning system sucks in air from outside, treats it and pushes it into the cabin or car. Its a closed-loop system that can pull a little bit of fresh air.

A bus or subway car can have 10 to 18 air exchanges per hour on the low side, according to Jim Alosi, a former Massachusetts secretary of transportation who is now a lecturer on transportation policy planning at MITs Department of Urban Studies and Planning; on the high side, it might have 40 to 50.

Everything depends on the age of the equipment, Alosi said. Older systems are not as efficient as newer ones.

Ventilated air that is well-mixed has good circulation and is relatively safe, said Varghese Mathai, an assistant professor in the Department of Physics at the University of Massachusetts-Amherst who has done studies on how the coronavirus spreads in an environment.

But when ventilation is not as good, the air is not so well-mixed, and there can be zones inside a room with a higher concentration of particles.

One cant really predict where these zones are not well-mixed in a room. Really, its a multidimensional problem, and its not easy to predict in a not-so-well-mixed room how safe it is to stay for an extended duration of time, Mathai said.

And if the transportation system wants maximum efficiency to cool or heat the air in a cabin, it can shut off the air intake and use whats already inside, explained Aly Tawfik, director of the Fresno State Transportation Institute and an assistant professor in the Department of Civil and Geomatics Engineering at California State University, Fresno.

Buses have filters, just like the ones inside our vehicles, Tawfik said. But they are not designed for viruses like the coronavirus or the flu virus.

In May 2020, Tawfik and his team did an experiment to see how a virus could spread through buses with a typical ventilation system.

Using nontoxic colored candles and steam, they simulated how air flowed in a variety of buses. They found that HVAC systems are extremely efficient and hold cool or the warm air inside a bus a lot longer than some may expect.

When the team introduced smoke, they saw that it spread in seconds and filled the whole cabin. Even when they opened the doors and introduced fresh air into the HVAC systems, the smoke lingered for minutes. The researchers think the virus behaves like the smoke did and could linger even after an infected person has left a bus.

These were unpleasant findings, because it means that opening the doors and windows doesnt help much, Tawfik said. The systems were designed to treat air fast and keep it inside the cabin for a long period of time.

With another experiment, the team tried to see if they could treat the air to make it safer. They tested the buses with three viruses that were similar to the coronavirus.

Cooling the air mitigated an average of about 80% of the viruses, and heating was at about 90%.

That does not necessarily mean that its safe, because this 10% is still millions of viruses, Tawfik said. For one thing, its not clear how much of the virus virus it takes to infect someone.

HEPA filters mitigated about 94% of the viruses. Ionizers were a little less efficient, but photocatalytic oxidation and UV lights were better. UV lights in the HVAC system removed about 99% of the viruses.

Northern Californias BART system and New Yorks Metro system are among those that have introduced some of these technologies during the pandemic.

People can catch Covid-19 on planes, especially when an infected person isnt wearing a mask, studies have shown, but a planes air system is much stronger than one on a bus or train.

Airplanes use HEPA filters that can capture about 99% of particles in the air. They also have better air circulation when flying. Air is typically fed in through the top of the cabin, extracted by floor vents, fed through those filters and eventually sent back into the cabin.

Planes bring in air in a top-to-bottom direction about 20 to 30 times per hour, creating a 50-50 mix of outside and recirculated air and reducing the potential spread of the virus. So the risk of getting sick is low, the experts say.

However, people are usually on planes a lot longer than they may be on a subway or on a bus, and more time in a crowded plane can increase someones exposure.

When a plane is parked, it does not have that superior circulation.

Airplane systems are a little similar to bus systems when they are on the ground, Tawfik said. Thats why youll notice the temperature isnt as well-regulated then, and its also when there isnt the same amount of fresh air circulating. Its then dealing with the same challenges.

Uber and Lyft have dropped their mask mandates, and many taxi companies have stopped requiring masks.

Infection in a car is certainly possible, studies show.

You can always wear a mask, and some experts suggest opening car windows and keeping talk to a minimum. Keep in mind that shorter rides are also better than longer ones.

Alosi said there are things that transportation systems could do to mitigate some of the risk. Trains and buses could run more often so there arent as many people on board, for instance.

He says it could help to require people to show proof of vaccination if they want to get on a train or plane. That probably wouldnt work with subways or buses, though, nor would it fly politically.

Alosi thinks public transportation has been unfairly stigmatized. If youre not up in arms about people being unmasked in the grocery store, you should chill out about public transit, he said.

Even before masks were mandatory on public transportation, studies have found, mass transit systems dont seem to be major drivers of viral spread.

And although its not mandatory, the US Centers for Disease Control and Prevention still recommends that people wear masks in indoor public transportation settings.

When you spend significant duration indoors, you obviously inhale, and if you have co-occupants who are potentially infected, you can inhale these tiny droplets that can get you sick, Mathai said.

Ventilation absolutely helps, he said, but protecting yourself can take multiple tools of mitigation. Masks really reduce the momentum of these released aerosol droplets.

A mask can even protect you when others arent wearing them.

Just wearing a mask is a such a simple solution to increasing the level of safety, Pollitt said. Putting one on, its an easy thing to do.

Go here to read the rest:

Ventilation helps make public transit safer from spread of Covid-19, experts say, but masks are better - CNN

Norway is open to 4th COVID-19 shot to people over 80 – ABC News

April 20, 2022

Norwegian health authorities say they are open to giving people aged 80 and above a booster shot of the COVID-19 vaccine but see no cause for a general recommendation for that age category to get a fourth shot

ByThe Associated Press

April 20, 2022, 1:14 PM

1 min read

COPENHAGEN, Denmark -- Norwegian health authorities said Wednesday they are open to giving people aged 80 and above a booster shot of the COVID-19 vaccine, but see no cause for a general recommendation for that age category to get a fourth shot.

Geir Bukholm, assistant director at the Norwegian Institute of Public Health, said the agency believes this can be assessed and chosen by the individual.

However, the agency urged more people with severely weakened immune systems to take a booster shot of the vaccine.

The agency said the updated assessment was in line with guidelines by the European Infection Control Agency and the European Medicines Agency.

In neighboring Sweden, authorities this month recommended a fourth vaccine dose for people 65 and over and for those living in nursing homes or getting home care, down from an earlier recommendation for people 80 and older. The recommendation also includes fourth shots for those aged 1864 with moderate to severe immune deficiency.

Follow all of APs pandemic coverage at https://apnews.com/hub/coronavirus-pandemic

See the rest here:

Norway is open to 4th COVID-19 shot to people over 80 - ABC News

Shingles risk increased in people over 50 after COVID-19 diagnosis, says study – SILive.com

April 20, 2022

STATEN ISLAND, N.Y. People 50 and older were found to be at increased risk of developing shingles after a COVID-19 diagnosis, a new study found, marking the first time a large analysis has connected the painful infection to the disease which has now persisted for more than two years.

Researchers used a database to track nearly 400,000 people 50 and older who were infected for the first time between the first days of the pandemic and the early months of 2021 and compared findings against a cohort of nearly 1.6 million people who were not diagnosed with the disease.

The study, published in the journal Open Form Infectious Diseases, found those who tested positive for COVID-19 were 15% more likely to develop shingles, known as herpes zoster, compared to the control group. That risk was even more pronounced 21% higher for hospitalized COVID-19 patients.

People vaccinated against shingles and COVID-19 were not included in the study. The research was conducted prior to the emergence of the virulent omicron variant, and it is unclear if the newer strain is associated with differing levels of shingles diagnoses.

We found that during the first year of the COVID-19 pandemic, 50-year-old individuals with a first-time COVID-19 diagnosis had a significantly higher risk of developing HZ (herpes zoster) than those never diagnosed with COVID-19, the study authors wrote.

Shingles is an infection that often manifests as a painful rash in a single stripe on one side of the body. It can also cause a rash on one side of the face, potentially affecting vision, according to the Centers for Disease Control and Prevention (CDC).

The rash includes blisters that scab over in about a week before clearing over the span of two weeks to a full month. Around one in three people in the United States develop shingles, the CDC said.

Anyone who previously had chicken pox has the potential to get shingles, especially later in life as the immune system weakens. That is because the virus that causes chicken pox, varicella zoster, lays dormant in the body after an initial infection and can reemerge later in life and cause shingles.

Researchers in the latest study said their findings suggested COVID-19 infection may trigger reactivation of the chicken pox virus, prompting shingles to form.

Previous studies hypothesized COVID-19s ability to disrupt the bodys T-cells, the part of the immune system that fights infections, is the reason for the diseases ability to cause higher rates of shingles infections.

A separate Brazilian study found a 35% increase in shingles diagnoses in the first months of the pandemic compared to the same periods in 2017 to 2019.

The scientists involved in the latest study said health professionals should consider that COVID-19 may be a risk factor for shingles, adding that maintaining recommended shingles vaccination among the 50 and older age group could blunt the impact of the overall increase in new infections.

Original post:

Shingles risk increased in people over 50 after COVID-19 diagnosis, says study - SILive.com

COVID-19 re-infection can happen sooner than you think, CDC study says – FOX 32 Chicago

April 20, 2022

An unvaccinated teenager who tested positive for the COVID-19 Delta variant last year was re-infected with the Omicron variant in as little as 23 days, according to a case study that looked at potential limitations of "infection-induced" immunity from COVID-19.

The study by the U.S. Centers for Disease Control and Prevention (CDC) analyzed 10 people who reported "early re-infections," or those who tested positive for the Omicron variant within 90 days of testing positive for the Delta variant. Delta was the dominant strain in the U.S. until Omicron took over in December 2021.

Among the 10 people studied - five from Vermont, three from Wisconsin, one from Washington state and one from Rhode Island - the shortest time between infections was the teenager in Washington with 23 days. The longest was 87 days.

RELATED: Moderna hopes to offer updated COVID-19 booster for latest variant this fall

Eight of the people studied were younger than 18, and only one had received a full series of COVID-19 vaccines. They werent eligible for a booster at the time of re-infection. No other patient was up-to-date on recommended COVID vaccines.

The CDC says vaccinations provide additional protection against COVID-19, even if youve been infected before.

The agency warns that the findings "might not be generalized to the U.S. population," and the data is limited to the transition period when Omicron surpassed Delta as the dominant U.S. strain.

"Nonetheless, this study highlights potential limits of infection-induced immunity against novel variants," the study concludes. "Although the epidemiology of COVID-19 might change as new variants emerge, vaccination remains the safest strategy."

RELATED: Federal transportation mask mandate struck down: What now?

The study was published about a week before a Florida judge ended the sweeping federal mask mandate on planes, trains and in transit hubs, the last of major pandemic rules at the federal level. The Justice Department said it wont appeal the judges ruling unless the CDC believes the requirement is still necessary.

Passengers on a Delta Airlines flight clapped as the captain announced that they were no longer required to wear face masks on board on April 18, 2022. Credit: Leticia Elisea via Storyful

As of Tuesday, the CDC had not made a determination.

New reported U.S. cases of COVID-19 are relatively low compared with the past two years, but they have increased lately and are likely an undercount. Hospitalizations are nearly flat and deaths are still declining, according to the Associated Press.

View post:

COVID-19 re-infection can happen sooner than you think, CDC study says - FOX 32 Chicago

The Omicron XE COVID-19 variant here’s what we know so far – World Economic Forum

April 20, 2022

As the COVID pandemic has progressed, weve repeatedly seen the arrival of new viral variants. Variants of concern, such as delta and omicron, are versions of SARS-CoV-2 (the virus that causes COVID-19) which have acquired mutations. These mutations can provide SARS-CoV-2 with a genetic advantage so for example, delta is linked to more serious illness than the original Wuhan strain, while omicron is more infectious.

Now we are seeing recombinant variants such as omicron XE. These are not viruses which have picked up a few mutations. Instead, they are viruses containing a combination of genetic material from multiple variants, producing a new version of the SARS-CoV-2 virus.

So far there have been at least 1,179 cases of omicron XE identified in the UK (this was the figure in the most recent update from the UK Health Security Agency published on April 8). The majority of these cases have been in the south and east of England. There have also been reports of a handful of cases elsewhere around the world, likely due to international travel.

So how worried should we be about omicron XE? While we dont know a lot about it yet, what we do know doesnt suggest theres cause for serious concern. Lets take a look.

When viruses replicate, they sometimes make mistakes in their genetic code leading to individual mutations. Often, these mutations dont result in any change to the structure of the virus termed silent mutations. Some mutations, however, can confer an advantage. For example, mutations that occur in the spike protein (the part of SARS-CoV-2 responsible for infecting our cells) can make the virus more transmissible than previous variants. Weve seen repeated mutations in the spike protein producing variants of concern.

Recombination is a different process, whereby two different variants infect the same cell, in the same person, at the same time. From there, they can combine their genetic material, resulting in a virus that possesses a mix of genes from both infecting parent viruses. This recombinant variant may then spread to other people as has been the case with omicron XE.

'Recombination occurs when two different variants infect the same cell at the same time'.

Image: The Conversation/Grace C. Roberts

In fact, multiple recombinant variants have been identified globally by PANGOLIN (the SARS-CoV-2 lineage surveillance carried out by the COVID-19 genetics UK consortium). At least three of these XD, XE and XF have been detected in the UK.

Some recombinants, such as XD and XF, are combinations of the delta variant with omicron lineages. You might have heard of these hybrids, which have been dubbed deltacron. Omicron XE, however, is a combination of two omicron strains: BA.1 and BA.2.

Genetic recombination of viruses is not a new phenomenon. It occurs regularly with viruses such as influenza and HIV. Indeed, one of the proposed origins of the original Wuhan SARS-CoV-2 virus is from a recombination event in bats.

From an evolutionary perspective, recombination offers viruses an advantage, as it allows more rapid and significant changes to the virus, compared with the slower process of acquiring mutations through errors in replication. Recombinant viruses can exhibit marked changes in their behaviour, such as increased infectiousness, evasion of our existing immunity to the virus, or resistance to drugs. Much like error-based mutation, however, some recombinant viruses show no apparent differences to their parent viruses.

We know that omicron XE has the majority of its genetic information, including the spike protein, from the omicron sub-variant BA.2, which is the variant predominating in the UK at the moment. It is likely, therefore, that the characteristics of omicron XE (such as transmissibility, severity of disease and vaccine efficacy) are similar to those of BA.2. But its prudent that scientists continue to monitor and study omicron XE, as it is a genetically distinct virus from its parents.

Initial data for the omicron XE variant suggests that the growth rate (that is, the proportion of new infections in the population) is slightly higher than that of omicron BA.2. However, because there are only a small number of infections with XE at present, the data we have on this is limited and its difficult to draw solid conclusions for now.

Reassuringly, we know that BA.2 is no more severe than BA.1, and that omicron variants overall tend to cause less severe disease than previous SARS-CoV-2 variants. But they are highly infectious.

The first global pandemic in more than 100 years, COVID-19 has spread throughout the world at an unprecedented speed. At the time of writing, 4.5 million cases have been confirmed and more than 300,000 people have died due to the virus.

As countries seek to recover, some of the more long-term economic, business, environmental, societal and technological challenges and opportunities are just beginning to become visible.

To help all stakeholders communities, governments, businesses and individuals understand the emerging risks and follow-on effects generated by the impact of the coronavirus pandemic, the World Economic Forum, in collaboration with Marsh and McLennan and Zurich Insurance Group, has launched its COVID-19 Risks Outlook: A Preliminary Mapping and its Implications - a companion for decision-makers, building on the Forums annual Global Risks Report.

Companies are invited to join the Forums work to help manage the identified emerging risks of COVID-19 across industries to shape a better future. Read the full COVID-19 Risks Outlook: A Preliminary Mapping and its Implications report here, and our impact story with further information.

The need for updated vaccines is becoming ever-pressing since all current vaccines are based on the original Wuhan strain. Data has shown that the more changes in the spike protein subsequent variants have acquired, the less effective our current vaccines are at preventing infection. That said, vaccines are still very effective at preventing severe disease or death from COVID.

Of course, we need more research to understand the characteristics of this new omicron XE strain. But it appears, at present, to be very similar to the current circulating strains of SARS-CoV-2. As we well know, its not the first variant of the virus, and its highly unlikely to be the last.

Read the original:

The Omicron XE COVID-19 variant here's what we know so far - World Economic Forum

Shanghai Slowly Turning the Corner from Strict COVID-19 Lockdown – Voice of America – VOA News

April 20, 2022

Authorities in the Chinese financial hub, Shanghai, released another 4 million people from its strict COVID-19 lockdown rules as part of the citys efforts to restore its economic activity.

Officials announced seven new COVID-19 deaths Wednesday, bringing the death toll from the current outbreak to 17, although those numbers have been questioned by international health officials. Chinas second-largest city also reported more than 18,000 new COVID-19 cases Wednesday.

Shanghais 26 million residents have been ordered to remain in their homes since early April in response to the surge of new COVID-19 infections largely driven by the highly contagious omicron variant.

The breakthrough of new COVID-19 cases in China is happening despite Beijings official zero COVID strategy that aims to completely eliminate coronavirus outbreaks across the mainland.

The lockdown has led to growing complaints online of a lack of fresh food, especially vegetables, with grocery stores closed and residents unable to obtain food deliveries through online apps. The anger has led to an unusual amount of public protests, including one where residents screamed in unison from the open windows of their high-rise apartments that was caught on video and went viral on social media.

A total of 12 million Shanghai residents have been given permission to venture outside their homes since authorities introduced guidelines last week that allows movement in neighborhoods with no recorded cases over the past 14 days.

Some factories in Shanghai are slowly resuming operations, including electric car company Tesla, which restarted production Tuesday after being idled for about three weeks. More than 600 firms are on a list of key industries and companies that have been allowed to either resume or keep their operations running.

Some information for this report came from The Associated Press, Reuters, Agence France-Presse.

Read more:

Shanghai Slowly Turning the Corner from Strict COVID-19 Lockdown - Voice of America - VOA News

Regional Bureau for the Middle East and North Africa: COVID-19 Response, 2021 Year-End Report (January December 2021) – Algeria – ReliefWeb

April 20, 2022

Key Figures

17.4 million* people of concern in the Middle East and North Africa *(2021 planning figures)

29,000 cases of COVID-19 reported among people of concern to UNHCR since March 2020, including fatalities

19 out of 19 countries in the MENA region have started COVID-19 vaccinations for refugees

Regional Developments

In 2021, UNHCR and partners continued to provide support and deliver protection and assistance to refugees, asylum-seekers, and internally displaced people (IDPs) across the MENA region. This included supporting access to health and education services, and providing shelter and cash assistance, which remained essential to people of concern; some 826,000 unique individuals were reached with emergency cash assistance for the COVID-19 response to the value of $43 million. Notably, UNHCR advocacy contributed to the inclusion of refugees in national COVID-19 responses across the region, including for testing and treatment, and in all countries for COVID-19 vaccination.

Throughout the year, UNHCR continued to support local COVID-19 health responses and sensitization activities through Risk Communication and Community Engagement, while vaccination campaigns were further reinforced by national health authorities, as booster shots were introduced by some to mitigate the spread of the virus.

In 2022, UNHCRs COVID-19 response will continue to focus on advocating for the inclusion of people of concern to UNHCR in national public health systems and other national responses. Given that significant numbers of people of concern remain vulnerable and in hardship, exacerbated by the pandemic, UNHCR will continue to mitigate the negative socioeconomic and protection impacts of COVID-19, particularly through cash programming and community outreach. COVID-19 programming, including in the areas of protection, health, basic needs, WASH, shelter, and camp coordination and camp management (CCCM), are mainstreamed into annual planning and presented in the Global Appeal and an overview is available here.

See the rest here:

Regional Bureau for the Middle East and North Africa: COVID-19 Response, 2021 Year-End Report (January December 2021) - Algeria - ReliefWeb

Covid-19: India accused of trying to delay WHO revision of death toll – The Guardian

April 19, 2022

India has been accused of attempting to delay an effort by the World Health Organization to revise the global death toll from Covid-19 after its calculations suggested that the country had undercounted its dead by an estimated 3.5 million.

Indias official number of deaths from Covid is 520,000. But according to in-depth analysis and investigations into the data by WHO, the total is more than 4 million, which would be by far the highest country death toll in the world.

The figure tallies with previous estimates made by scientists, data analysts and medical journals that the true number of deaths from Covid in India was up to 10 times higher than that recorded in official statistics.

After the country was engulfed in a devastating second wave in April 2021, central and state governments were accused of covering up the real numbers of those died from the virus in order to deflect accusations that not enough was done to prevent its spread or provide adequate healthcare, medicine and oxygen.

According to reports, the WHO had wanted to release the data in January but have received considerable pushback from the Indian government, which have refused to accept the figure and methodology as correct.

The WHO has stated it now intend to publish this month the revised data, which estimates 15 million people have died from Covid, more than double the 6 million known deaths. The updated figure, which is drawn from excess death data among other figures, also includes those who died from other illnesses but could not be treated because of Covid.

Addressing a New York Times report in which the accusation was made, the Indian government said it was in discussion with the WHO. Indias basic objection has not been with the result (whatever they might have been) but rather the methodology adopted for the same, it said in an statement, which alleged the mathematical modelling was questionable and statistically unproven.

However, Jon Wakefield, a professor of statistics and biostatistics at the University of Washington who was one of those involved in the modelling for the WHO, released a statement that explained the methodology in detail and rebutted the claims made by the Indian government about the veracity of the modelling.

There are fears India may be facing another imminent wave of coronavirus after daily cases jumped by 90% this week and the rate of positive test results rose from 0.3% to 0.8% overnight, with much of the surge in Delhi.

Read the original post:

Covid-19: India accused of trying to delay WHO revision of death toll - The Guardian

Amazon’s COVID-19 testing facility in Hebron to close; 150 jobs to be lost – The Cincinnati Enquirer

April 19, 2022

A COVID-19 testing facility constructed in Hebron during the pandemic to test Amazon employees will close its lab operations in July and lay off 150 workers, according to acompany letter sent to Kentucky officials

The facility, which was built in a warehouse near theCincinnati/Northern Kentucky International Airport, was one of two diagnostic testing centers Amazon assembled at the height of the pandemic as outbreaks occurred among warehouse workers in multiple areas across the country. The decision to close the testing center will not affect the growing Amazon Air hub at CVG.

By February 11, 2021, the Kentucky lab had tested more than 1 million Amazon employees for COVID-19, according to a news release.

But as cases have dwindled followingthe rapid omicron surge earlier this year, and rapid at-home testing which was offered to all Americans by the federal government has increased, the need for testing facilities such as the one in Hebron,havedropped significantly.

More: 'Amazon's not telling us the truth,' NKY fulfillment center employee organizes protest in midst of COVID-19 pandemic

More: Amazon: Inside the company's newest and biggest air hub

In a March 23 letter to Kentucky Career Services branch officemanager Michelle DeJohn and Boone County Judge/Executive Gary W. Moore, Amazon said it would begin ceasing testing operations at the Point Pleasant Road facility in July and noted certain employees would begin separation from working at the facility in June.

"Employee separations resulting from this action are expected to be permanent," Amazon human resources director Jen Detmer wrote in the letter. "The affected employees are not represented by a union or any other collective bargaining representative."

The letter said employee "separations" would take place on June 1, Sept. 4, and Nov. 1.

In July 2021, Amazon began selling at-home COVID-19 tests to the public that were then shipped to the company's Hebron lab and tested within 24 hours. The test kit cost $39.99.

In addition to at-home tests, the Hebron facility processed tests from more than 700 testing sites for Amazon workers.

The reason for erecting the laboratory was "a final step, on top of all our onsite COVID-19 precautions to ensure the health and safety of our front-line workers," according to AmazonVice President Cem Sibay.

The positions being eliminated from the facility range from medical lab managers to support engineers.

More:

Amazon's COVID-19 testing facility in Hebron to close; 150 jobs to be lost - The Cincinnati Enquirer

Page 330«..1020..329330331332..340350..»